Health care sustainability is an issue on the minds of many Canadians. Although we are fiercely proud of our health care system, we worry about whether it can continue in the face of spiralling health care budgets.
Grounded in the belief that pharmacists and pharmaceutical care can contribute significantly to curbing health care costs, Pharmaceutical Sciences at UBC has developed the $2.3-million Initiative for Sustainable Health Care in partnership with a consortium of industry partners. The Initiative aims to provide a neutral, balancing voice and an opportunity for ongoing dialogue and research on economic principles of health care sustainability, with a focus on the role of pharmacy and pharmaceuticals in affecting change.
The Initiative is led by a Professorship in Sustainable Health Care, who will work with an Advisory Council comprised of members representing industry, government and academia. The goal is to build integrated relationships between stakeholders in order to create together a sustainable and effective health care system. Pharmacy students will be educated to be thought leaders prepared to have a voice in decision-making for access to beneficial medications for their patients.
Dr. Mark Harrison has been appointed the inaugural holder of the Professorship in Sustainable Health Care, effective August 2014. The position is also affiliated with the Collaboration for Outcomes Research and Evaluation (CORE) research group at UBC.
The Initiative includes the Story of Medicines exhibit as its community education and outreach arm, designed to showcase the essential contribution of pharmacy and the pharmaceutical sciences to human health.
The consortium supporting the Initiative for Sustainable Health Care include Founding Partners Amgen, AstraZeneca, Eli Lilly, GSK, Merck, Novartis, and Pfizer, and Member Companies Boehringer Ingelheim, Lundbeck Canada, Hoffmann-LaRoche and LifeScan.